Skip to main content

Closed

KALA: KALA BIO, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-281.5%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-13.9×

Current ratio7.91×

KALA BIO, Inc.

KALANASDAQ Global Select·USD·Closed

KALA BIO, Inc.

KALANASDAQ·USD·Closed

$0.76

+3.59%

$0.76

+$0.03 (3.59%)

52W Range

0thpctl

Volume

0.50×avg

Mkt Cap

14.62MUSD

P/E

-0.2TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.50×avg

Market Cap

14.62MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings